Literature DB >> 10754202

The marine compound spisulosine, an inhibitor of cell proliferation, promotes the disassembly of actin stress fibers.

R Cuadros1, E Montejo de Garcini, F Wandosell, G Faircloth, J M Fernández-Sousa, J Avila.   

Abstract

Spisulosine is a novel antiproliferative (antitumoral) compound of marine origin. In this work the molecular target for this toxic agent has been analyzed. In the presence of spisulosine, cultured cells change their morphology, first acquiring a fusiform morphology, and later becoming rounded without focal adhesions. Analysis of the cytoskeleton of treated cells indicate the absence of actin stress fibers.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10754202     DOI: 10.1016/s0304-3835(99)00428-0

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  35 in total

Review 1.  Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics.

Authors:  Alfred H Merrill
Journal:  Chem Rev       Date:  2011-09-26       Impact factor: 60.622

2.  Drug discovery from natural sources.

Authors:  Young-Won Chin; Marcy J Balunas; Hee Byung Chai; A Douglas Kinghorn
Journal:  AAPS J       Date:  2006-04-14       Impact factor: 4.009

3.  L-Serine Deficiency Elicits Intracellular Accumulation of Cytotoxic Deoxysphingolipids and Lipid Body Formation.

Authors:  Kayoko Esaki; Tomoko Sayano; Chiaki Sonoda; Takumi Akagi; Takeshi Suzuki; Takuya Ogawa; Masahiro Okamoto; Takeo Yoshikawa; Yoshio Hirabayashi; Shigeki Furuya
Journal:  J Biol Chem       Date:  2015-04-22       Impact factor: 5.157

Review 4.  Marine Mollusk-Derived Agents with Antiproliferative Activity as Promising Anticancer Agents to Overcome Chemotherapy Resistance.

Authors:  Maria Letizia Ciavatta; Florence Lefranc; Marianna Carbone; Ernesto Mollo; Margherita Gavagnin; Tania Betancourt; Ramesh Dasari; Alexander Kornienko; Robert Kiss
Journal:  Med Res Rev       Date:  2016-12-07       Impact factor: 12.944

Review 5.  Human genetic disorders of sphingolipid biosynthesis.

Authors:  Leonardo Astudillo; Frédérique Sabourdy; Nicole Therville; Heiko Bode; Bruno Ségui; Nathalie Andrieu-Abadie; Thorsten Hornemann; Thierry Levade
Journal:  J Inherit Metab Dis       Date:  2014-08-21       Impact factor: 4.982

6.  Phase I dose-escalating study of ES-285 given as a three-hour intravenous infusion every three weeks in patients with advanced malignant solid tumors.

Authors:  C Massard; R Salazar; J P Armand; M Majem; E Deutsch; M García; A Oaknin; E M Fernández-García; A Soto; J C Soria
Journal:  Invest New Drugs       Date:  2012-01-04       Impact factor: 3.850

Review 7.  High-value compounds from the molluscs of marine and estuarine ecosystems as prospective functional food ingredients: An overview.

Authors:  Kajal Chakraborty; Minju Joy
Journal:  Food Res Int       Date:  2020-08-31       Impact factor: 6.475

8.  Cytotoxic 1-deoxysphingolipids are metabolized by a cytochrome P450-dependent pathway.

Authors:  Irina Alecu; Alaa Othman; Anke Penno; Essa M Saied; Christoph Arenz; Arnold von Eckardstein; Thorsten Hornemann
Journal:  J Lipid Res       Date:  2016-11-21       Impact factor: 5.922

9.  D-Glucosamine-derived synthons for assembly of L-threo-sphingoid bases. Total synthesis of rhizochalinin C.

Authors:  Jaeyoung Ko; Tadeusz F Molinski
Journal:  J Org Chem       Date:  2012-12-27       Impact factor: 4.354

10.  Deoxysphingoid bases as plasma markers in diabetes mellitus.

Authors:  Mariana Bertea; Markus F Rütti; Alaa Othman; Jaqueline Marti-Jaun; Martin Hersberger; Arnold von Eckardstein; Thorsten Hornemann
Journal:  Lipids Health Dis       Date:  2010-08-16       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.